Medicines that treat HIV are called antiretroviral therapy (ART). Genvoya is a combination tablet that contains the following four medicines that work together to treat HIV. Cobicistat is a “booster.” ...

Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Florida's recent decision to narrow eligibility for the Ryan White AIDS Drug Assistance Program (ADAP) is expected to limit ...

People with HIV have a virus that spreads in their body and damages the immune system, making it easier for them to get very sick from other infections. The medicine contained in Sunlenca works ...

Immunotherapy has revolutionized treatment options in oncology, neurology, and many infectious diseases and now there is fresh hope that the same method could be used to treat or functionally cure HIV ...

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

Keeping up with HIV treatment isn’t always easy. Anyone can face setbacks along the way. Staying on top of doctor’s appointments and taking medications regularly can feel overwhelming to manage ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with drug-resistant infections in 2022. While there is still no vaccine for the ...

TB remains the leading cause of death among people living with HIV. Uganda is a high TB-burden country, and HIV accelerates ...